""Emile Loria"" — Epstein Files Search

Search Entities About Settings

/to search

Dataset

Sort

Status

DOJ Status

Date Range

–

Page Count

–

2 results for “"Emile Loria"”

EFTA01113739Set 9

Pharmar12)' Dominique Costantini, M.D CEO Severe Orphan Emile Loria, M.D. Lung Diseases Chairman Corporate Presentation February 2013 EFTA01113739 OSE Pharma Investment Thesis Substantial late stage clinical assets: Phase 3 study ... Fibrosis: re-profiling existing drug with safety package Experienced team with solid track records

Keyboard Shortcuts

/

Focus search

Esc

Blur input

O

Open PDF

←→

Paginate

Emile

Loria

, M.D., Former Epimmune Pres & CEO Dominique Costantini, M.D., Former BioAlliance founder & CEO More than ... network o Contributing to phase III protocol. OSE Pharmael:?' 32 EFTA01113770 Board of Directors

Emile

Loria

, M.D., Chairman o Former President & CEO of Epimmune (Nasdaq:EPMN), Science and Business expertise

https://www.justice.gov/epstein/files/DataSet%209/EFTA01113739.pdf

EFTA00953704Set 9

2013-02-133p761w

take-over of assets from the former company Epimunne, that was listed on NASDAQ. Emile Loria and Dominique Costantini, both MDs, are the co-founders of the company. Emile Loria

https://www.justice.gov/epstein/files/DataSet%209/EFTA00953704.pdf

Corpus: 1990-03-17 – 2025-12-01

December 2025

Mo

Tu

We

Th

Fr

Sa

Su

None

Light

Medium

Heavy

Results by Dataset2 total

Set 9

2